Is Electromed Stock a Good Investment?

Electromed Investment Advice

ELMD

To provide specific investment advice or recommendations on Electromed stock, we recommend investors consider the following general factors when evaluating Electromed. This will help you to make an informed decision on whether to include Electromed in one of your diversified portfolios:

Examine Electromed's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Electromed's leadership team and their track record. Good management can help Electromed navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Electromed's business and its evolving consumer preferences.
Compare Electromed's performance and market position to its competitors. Analyze how Electromed is positioned in terms of product offerings, innovation, and market share.
Check if Electromed pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Electromed's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Electromed stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Electromed is a good investment.

Sell

Buy

Strong Hold

Electromed advice module can be used to check and cross-verify current investment recommendation provided by analysts reviewing the company's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Electromed is not overpriced, please confirm all Electromed fundamentals, including its price to sales, cash per share, and the relationship between the number of shares shorted and ebitda . Given that Electromed has a number of shares shorted of 145.28 K, we urge you to verify Electromed market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance	Solid	Details
Volatility	Very steady	Details
Hype Condition	Under hyped	Details
Current Valuation	Fairly Valued	Details
Odds Of Distress	Very Low	Details
Economic Sensitivity	Almost mirrors the market	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Electromed Stock

Researching Electromed's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 28.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years.

To determine if Electromed is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Electromed's research are outlined below:

	About 28.0% of the company shares are held by company insiders
	Latest headline from MacroaxisInsider: Acquisition by Erickson Stan K. of 3000 shares of Electromed subject to Rule 16b-3

Electromed Quarterly Accounts Payable

1.78 Million

Electromed uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Electromed. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Electromed's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	13th of February 2024 Upcoming Quarterly Report	View
	31st of December 2023 Next Fiscal Quarter End	View

Earnings surprises can significantly impact Electromed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Electromed's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2012-02-13	2011-12-31	0.01	0.003	-0.007	70
2021-11-09	2021-09-30	0.06	0.05	-0.01	16
2020-05-12	2020-03-31	0.06	0.07	0.01	16
2016-11-08	2016-09-30	0.03	0.02	-0.01	33
2016-09-06	2016-06-30	0.05	0.04	-0.01	20
2016-05-10	2016-03-31	0.07	0.06	-0.01	14
2015-09-15	2015-06-30	0.02	0.03	0.01	50
2012-11-13	2012-09-30	-0.02	-0.01	0.01	50

Electromed's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 299.67 M.

Market Cap

114.49 Million

Electromed's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	0.09	0.09
Return On Capital Employed	0.13	0.08
Return On Assets	0.09	0.09
Return On Equity	0.10	0.06

The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

Determining Electromed's profitability involves analyzing its financial statements and using various financial metrics to determine if Electromed is a good buy. For example, gross profit margin measures Electromed's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Electromed's profitability and make more informed investment decisions.

Please note, the presentation of Electromed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Electromed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Electromed's management manipulating its earnings.

Evaluate Electromed's management efficiency

Electromed has return on total asset (ROA) of 0.0839 % which means that it generated a profit of $0.0839 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1253 %, meaning that it created $0.1253 on every $100 dollars invested by stockholders. Electromed's management efficiency ratios could be used to measure how well Electromed manages its routine affairs as well as how well it operates its assets and liabilities. At present, Electromed's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, Electromed's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 53.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 95 K.

	Last Reported	Projected for Next Year
Book Value Per Share	4.68	4.92
Tangible Book Value Per Share	4.61	4.84
Enterprise Value Over EBITDA	12.75	13.39
Price Book Value Ratio	3.13	2.65
Enterprise Value Multiple	12.75	13.39
Price Fair Value	3.13	2.65
Enterprise Value	94.6 M	99.4 M

Electromed has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.

Beta

0.264

Basic technical analysis of Electromed Stock

As of the 30th of January, Electromed shows the Coefficient Of Variation of 398.94, downside deviation of 2.41, and Mean Deviation of 2.2. Electromed technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Electromed coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Electromed is priced favorably, providing market reflects its regular price of 35.36 per share. Given that Electromed has jensen alpha of 0.6197, we urge you to verify Electromed's prevailing market performance to make sure the company can sustain itself at a future point.

Electromed's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Electromed insiders, such as employees or executives, is commonly permitted as long as it does not rely on Electromed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Electromed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Erickson Stan K. over a week ago Acquisition by Erickson Stan K. of 3000 shares of Electromed subject to Rule 16b-3
		James Cunniff over three weeks ago Disposition of 87500 shares by James Cunniff of Electromed subject to Rule 16b-3
		Kathleen Skarvan over a month ago Disposition of 40185 shares by Kathleen Skarvan of Electromed subject to Rule 16b-3
		Summers Andrew over a month ago Disposition of 6365 shares by Summers Andrew of Electromed at 29.861 subject to Rule 16b-3
		Summers Andrew over a month ago Disposition of 17718 shares by Summers Andrew of Electromed at 30.151 subject to Rule 16b-3
		Summers Andrew over a month ago Disposition of 8731 shares by Summers Andrew of Electromed at 30.183 subject to Rule 16b-3
		Summers Andrew over a month ago Acquisition by Summers Andrew of 3000 shares of Electromed subject to Rule 16b-3
		Kathleen Skarvan over two months ago Disposition of 56945 shares by Kathleen Skarvan of Electromed at 27.9706 subject to Rule 16b-3
		Fluet Gregory over two months ago Acquisition by Fluet Gregory of 3000 shares of Electromed subject to Rule 16b-3
		James Cunniff over three months ago Acquisition by James Cunniff of 15900 shares of Electromed subject to Rule 16b-3
		Craney Stephen H. over six months ago Acquisition by Craney Stephen H. of 10000 shares of Electromed at 8.5987 subject to Rule 16b-3
		Walsh Andrea M. over six months ago Acquisition by Walsh Andrea M. of 3000 shares of Electromed subject to Rule 16b-3

Electromed's Outstanding Corporate Bonds

Electromed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Electromed uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Electromed bonds can be classified according to their maturity, which is the date when Electromed has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Dana 575 percent Corp Bond US235822AB96	View
	Volcan Compania Minera Corp Bond USP98047AC08	View
	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	International Game Technology Corp Bond US460599AD57	View
	BNP Paribas FRN Corp Bond USF1R15XK367	View

View All Electromed Corporate Bonds

Understand Electromed's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Electromed's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.2173
	Market Risk Adjusted Performance	0.7044
	Mean Deviation	2.2
	Semi Deviation	1.97
	Downside Deviation	2.41
	Coefficient Of Variation	398.94
	Standard Deviation	2.81
	Variance	7.9
	Information Ratio	0.2205
	Jensen Alpha	0.6197
	Total Risk Alpha	0.4437
	Sortino Ratio	0.2576
	Treynor Ratio	0.6944
	Maximum Drawdown	12.17
	Value At Risk	(3.90)
	Potential Upside	5.82
	Downside Variance	5.79
	Semi Variance	3.87
	Expected Short fall	(2.63)
	Skewness	0.2638
	Kurtosis	0.2375

	Risk Adjusted Performance	0.2173
	Market Risk Adjusted Performance	0.7044
	Mean Deviation	2.2
	Semi Deviation	1.97
	Downside Deviation	2.41
	Coefficient Of Variation	398.94
	Standard Deviation	2.81
	Variance	7.9
	Information Ratio	0.2205
	Jensen Alpha	0.6197
	Total Risk Alpha	0.4437
	Sortino Ratio	0.2576
	Treynor Ratio	0.6944
	Maximum Drawdown	12.17
	Value At Risk	(3.90)
	Potential Upside	5.82
	Downside Variance	5.79
	Semi Variance	3.87
	Expected Short fall	(2.63)
	Skewness	0.2638
	Kurtosis	0.2375

Consider Electromed's intraday indicators

Electromed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Electromed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	1276.33
	Daily Balance Of Power	(0.09)
	Rate Of Daily Change	1.0
	Day Median Price	35.17
	Day Typical Price	35.23
	Price Action Indicator	0.16
	Period Momentum Indicator	(0.07)

Electromed Corporate Filings

F4	3rd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
F3	21st of November 2024 An amendment to the original Schedule 13D filing	View Verify
8K	18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about	View Verify
13A	13th of November 2024 An amended filing to the original Schedule 13G	View Verify

Electromed time-series forecasting models is one of many Electromed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Electromed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Electromed Stock media impact

Far too much social signal, news, headlines, and media speculation about Electromed that are available to investors today. That information is available publicly through Electromed media outlets and privately through word of mouth or via Electromed internal channels. However, regardless of the origin, that massive amount of Electromed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Electromed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Electromed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Electromed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Electromed alpha.

Electromed Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Electromed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Electromed Corporate Management

Amy Yanta	Quality Affairs	Profile
Brad Nagel	Chief Officer	Profile
Diane Kaufman	Vice Resources	Profile
William George	Secretary	Profile
Christopher Holland	Chief Officer	Profile

When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports: